Highlights
AMEX: SYN       Synthetic Biologics Inc
Last Price Today's Change   Day's Range   Trading Volume
0.553   +0.011 (2.03%)  0.55 - 0.58  323,000

Overview

 
Avg Volume (4 weeks):366,977
4 Weeks Range:0.475 - 0.62
4 Weeks Price Volatility (%):
53.79%
52 Weeks Range:0.365 - 0.85
52 Weeks Price Volatility (%):
38.76%
Average Price Target: 3.00
Price Target Upside/Downside: +2.447

Headlines



No recent Headlines for this stock.


Business Background

Synthetic Biologics is a late-stage biotechnology company focused on developing gut microbiome therapeutics. Its portfolio includes SYN-010, which is intended to treat the underlying causes of irritable bowel syndrome with constipation; and SYN-004 (ribaxamase), which aims to defend the gut microbiome from the effects of regularly used intravenous drugs for the prevention of C. difficile infection, antibiotic-associated diarrhea, and the emergence of antibiotic-resistant organisms. The company is also developing monoclonal antibody therapies for the treatment of pertussis and novel discovery-stage biotherapeutics for the treatment of phenylketonuria.

  Be the first to like this.
 


 

1843  6298  540  225 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 VXX 14.24+0.75 
 EEM 44.60-0.36 
 SPY 328.77-2.95 
 INTC 68.47+5.15 
 AMD 50.35-1.36 
 CHK 0.558-0.015 
 F 9.00-0.14 
 NIO 4.66-0.26 
 AVP 5.60-0.05 
 GE 11.71-0.06 
Partners & Brokers